» Articles » PMID: 18057795

[Effect of Propolis on Insulin Resistance in Fructose-drinking Rats]

Overview
Journal Yakugaku Zasshi
Specialties Pharmacology
Pharmacy
Date 2007 Dec 7
PMID 18057795
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Propolis, a honeybee product, contains a variety of biologically active substances. The present study was designed to investigate the effects of propolis on insulin resistance induced by fructose-drinking rats (FDR; type 2 diabetic animal model). Male Wistar rats (6 weeks old) received 15% fructose solution in drinking water for 8 weeks. FDR showed significant increases in plasma levels of insulin, Homeostasis Model Assessment ratio (HOMA-R, an index of insulin resistance), body weight, and systolic blood pressure but not blood glucose levels, when compared with control rats. Brazilian propolis extract (100 and 300 mg/kg, p.o.) treatment for 8 weeks significantly decreased the plasma level of insulin, HOMA-R, and body weight, increased plasma triglyceride levels without affecting blood glucose and total cholesterol levels, and tended to decrease systolic blood pressure. In isolated and perfused mesenteric vascular beds of FDR, propolis treatment resulted in a significant reduction of sympathetic nerve-mediated vasoconstrictor response to periarterial nerve stimulation (PNS; 8 Hz) and tended to increase the calcitonin gene-related peptide (CGRP) nerve-mediated vasodilator response to PNS, compared with those in untreated FDR. However, propolis treatment did not significantly affect norepinephrine-induced vasoconstriction and CGRP-induced vasodilation. These results suggest that propolis could be an effective functional food to prevent the development of insulin resistance.

Citing Articles

Propolis: An update on its chemistry and pharmacological applications.

Hossain R, Quispe C, Khan R, Saikat A, Ray P, Ongalbek D Chin Med. 2022; 17(1):100.

PMID: 36028892 PMC: 9412804. DOI: 10.1186/s13020-022-00651-2.


Potential Role of Propolis in the Prevention and Treatment of Metabolic Diseases.

Balica G, Vostinaru O, Stefanescu C, Mogosan C, Iaru I, Cristina A Plants (Basel). 2021; 10(5).

PMID: 33925692 PMC: 8144987. DOI: 10.3390/plants10050883.


Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: Running title: Propolis against SARS-CoV-2 infection and COVID-19.

Berretta A, Duarte Silveira M, Condor Capcha J, de Jong D Biomed Pharmacother. 2020; 131:110622.

PMID: 32890967 PMC: 7430291. DOI: 10.1016/j.biopha.2020.110622.


Molecular and cellular mechanisms of the effects of Propolis in inflammation, oxidative stress and glycemic control in chronic diseases.

Pahlavani N, Malekahmadi M, Firouzi S, Rostami D, Sedaghat A, Bagheri Moghaddam A Nutr Metab (Lond). 2020; 17:65.

PMID: 32817750 PMC: 7425411. DOI: 10.1186/s12986-020-00485-5.


Chinese Propolis Prevents Obesity and Metabolism Syndromes Induced by a High Fat Diet and Accompanied by an Altered Gut Microbiota Structure in Mice.

Zheng Y, Wu Y, Tao L, Chen X, Jones T, Wang K Nutrients. 2020; 12(4).

PMID: 32235581 PMC: 7230861. DOI: 10.3390/nu12040959.